{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:05:23Z","timestamp":1791313523287,"version":"4.3.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018493","name":"Taipei Medical University Shuang Ho Hospital Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["113FRP-10"],"award-info":[{"award-number":["113FRP-10"]}],"id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-038-060"],"award-info":[{"award-number":["NSTC 113-2314-B-038-060"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-038-084"],"award-info":[{"award-number":["NSTC 113-2314-B-038-084"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118275","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T13:16:58Z","timestamp":1750166218000},"page":"118275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cilostazol attenuates vascular inflammation via the regulation of TICAM1\/IRF3 signaling pathway"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-390X","authenticated-orcid":false,"given":"Hui-Wen","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Che","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6292-7117","authenticated-orcid":false,"given":"Li-Chin","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118275_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12916-024-03527-4","article-title":"Comparative analysis of atherosclerotic cardiovascular disease burden between ages 20-54 and over 55 years: insights from the Global Burden of Disease Study 2019","volume":"22","author":"Li","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.biopha.2025.118275_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and Inflammation in Atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118275_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.787541","article-title":"Dysfunctional vascular endothelium as a driver of atherosclerosis: emerging insights into pathogenesis and treatment","volume":"12","author":"Botts","year":"2021","journal-title":"Front. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118275_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacl.2017.06.015","article-title":"Residual atherosclerotic cardiovascular disease risk in statin-treated adults: the multi-ethnic study of atherosclerosis","volume":"11","author":"Wong","year":"2017","journal-title":"J. Clin. Lipido"},{"key":"10.1016\/j.biopha.2025.118275_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2025.118275_bib6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2025.118275_bib7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118275_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118275_bib9","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118275_bib10","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118275_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2025.118275_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118275_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3892\/etm.2020.8733","article-title":"Rosuvastatin protects against endothelial cell apoptosis in vitro and alleviates atherosclerosis in ApoE(-\/-) mice by suppressing endoplasmic reticulum stress","volume":"20","author":"Geng","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2025.118275_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12959-020-00240-z","article-title":"Switching of vascular cells towards atherogenesis, and other factors contributing to atherosclerosis: a systematic review","volume":"18","author":"Shafi","year":"2020","journal-title":"Thromb. J."},{"key":"10.1016\/j.biopha.2025.118275_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/ddc2020017","article-title":"Virtual screening algorithms in drug discovery: a review focused on machine and deep learning methods","author":"Oliveira","year":"2023","journal-title":"Drugs Drug Candidates"},{"key":"10.1016\/j.biopha.2025.118275_bib16","first-page":"22","article-title":"Computer-aided drug design and drug discovery: a prospective analysis","volume":"17","author":"Niazi","year":"2023","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.biopha.2025.118275_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00706-023-03076-1","article-title":"Molecular docking in organic, inorganic, and hybrid systems: a tutorial review","volume":"154","author":"Mohanty","year":"2023","journal-title":"Mon. F. \u00fcR. Chem. Chem. Mon."},{"key":"10.1016\/j.biopha.2025.118275_bib18","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118275_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107830","article-title":"Ligand binding free energy evaluation by Monte Carlo Recursion","volume":"103","author":"de Souza","year":"2023","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118275_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-2836(82)90153-X","article-title":"A geometric approach to macromolecule-ligand interactions","volume":"161","author":"Kuntz","year":"1982","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118275_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s42514-021-00086-5","article-title":"Molecular docking-based computational platform for high-throughput virtual screening","volume":"4","author":"Zhang","year":"2022","journal-title":"CCF Trans. High. Perform. Comput."},{"key":"10.1016\/j.biopha.2025.118275_bib22","first-page":"206","article-title":"Proteome-scale deployment of protein structure prediction workflows on the summit supercomputer","volume":"2022","author":"Gao","year":"2022","journal-title":"IEEE Int. Parallel Distrib. Process. Symp Workshops (IPDPSW)"},{"key":"10.1016\/j.biopha.2025.118275_bib23","doi-asserted-by":"crossref","DOI":"10.1063\/5.0144361","article-title":"An exa-scale high-performance molecular dynamics simulation program: MODYLAS","volume":"158","author":"Andoh","year":"2023","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.biopha.2025.118275_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/ph15010063","article-title":"A review on parallel virtual screening softwares for high-performance computers","volume":"15","author":"Murugan","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.118275_bib25","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2025.118275_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131779","article-title":"Nattokinase attenuates endothelial inflammation through the activation of SRF and THBS1","volume":"268","author":"Chiu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.118275_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113565","article-title":"Matrix metalloproteinase-7 promotes chronic kidney disease progression via the induction of inflammasomes and the suppression of autophagy","volume":"154","author":"Zheng","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118275_bib28","doi-asserted-by":"crossref","first-page":"9582","DOI":"10.18632\/aging.202692","article-title":"LCZ696 ameliorates lipopolysaccharide-induced endothelial injury","volume":"13","author":"Gao","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2025.118275_bib29","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/aps.2013.46","article-title":"Astragalus polysaccharides suppress ICAM-1 and VCAM-1 expression in TNF-\u03b1-treated human vascular endothelial cells by blocking NF-\u03baB activation","volume":"34","author":"Zhu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2025.118275_bib30","doi-asserted-by":"crossref","first-page":"15176","DOI":"10.1016\/S0021-9258(18)42162-X","article-title":"Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha","volume":"267","author":"Weller","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118275_bib31","doi-asserted-by":"crossref","first-page":"6249085","DOI":"10.1155\/2018\/6249085","article-title":"TRIF regulates BIC\/miR-155 via the ERK signaling pathway to control the ox-LDL-induced macrophage inflammatory response","volume":"2018","author":"Wu","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biopha.2025.118275_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri3151","article-title":"Accessory molecules for Toll-like receptors and their function","volume":"12","author":"Lee","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118275_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12950-019-0212-4","article-title":"Role of autophagy in atherosclerosis: foe or friend?","volume":"16","author":"Hassanpour","year":"2019","journal-title":"J. Inflamm. (Lond. )"},{"key":"10.1016\/j.biopha.2025.118275_bib34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fphar.2018.00721","article-title":"L. Yue-Chun, The role of necroptosis in cardiovascular disease","volume":"9","author":"Zhe-Wei","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118275_bib35","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","article-title":"NLRP3 inflammasome in endothelial dysfunction","volume":"11","author":"Bai","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118275_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100130","article-title":"Inflammation and cardiovascular disease: from mechanisms to therapeutics","volume":"4","author":"Alfaddagh","year":"2020","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118275_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2025.118275_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.tcm.2021.08.015","article-title":"Implications for the role of lipopolysaccharide in the development of atherosclerosis","volume":"32","author":"Gorabi","year":"2022","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.118275_bib39","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.bcp.2009.01.009","article-title":"Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin","volume":"77","author":"Lee","year":"2009","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2025.118275_bib40","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/HYPERTENSIONAHA.116.08395","article-title":"Ablation of interferon regulatory factor 3 protects against atherosclerosis in apolipoprotein E-deficient mice","volume":"69","author":"Liu","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2025.118275_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1753425912447130","article-title":"The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice","volume":"19","author":"Richards","year":"2013","journal-title":"Innate Immun."},{"key":"10.1016\/j.biopha.2025.118275_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/HYPERTENSIONAHA.116.08486","article-title":"Ablation of interferon regulatory factor 3 promotes the stability of atherosclerotic plaques","volume":"69","author":"Okon","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2025.118275_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003031","article-title":"NLRP3 inflammasome expression and activation in human atherosclerosis","volume":"5","author":"Paramel Varghese","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2025.118275_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5551\/jat.RV17001","article-title":"Role of NLRP3 inflammasomes in atherosclerosis","volume":"24","author":"Karasawa","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.biopha.2025.118275_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012219","article-title":"Novel insights into the NLRP 3 inflammasome in atherosclerosis","volume":"8","author":"Jin","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"10.1016\/j.biopha.2025.118275_bib46","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.118275_bib47","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.2147\/JIR.S344730","article-title":"Spotlight on NLRP3 inflammasome: role in pathogenesis and therapies of atherosclerosis","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.biopha.2025.118275_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s43556-024-00179-x","article-title":"NLRP inflammasomes in health and disease","volume":"5","author":"Xu","year":"2024","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.biopha.2025.118275_bib49","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jds.2022.09.009","article-title":"Role of nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 6 in activation of inflammation in human umbilical vein endothelial cells stimulated by Porphyromonas gingivalis-an in vitro study","volume":"18","author":"Lou","year":"2023","journal-title":"J. Dent. Sci."},{"key":"10.1016\/j.biopha.2025.118275_bib50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jacbts.2016.08.002","article-title":"The role of necroptosis in atherosclerotic disease","volume":"1","author":"Leeper","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.biopha.2025.118275_bib51","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.3390\/ijms22126544","article-title":"Epigenetic regulation of autophagy in cardiovascular pathobiology","volume":"22","author":"Bu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118275_bib52","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/cells13100825","article-title":"The role of autophagy in vascular endothelial cell health and physiology","volume":"13","author":"Hu","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118275_bib53","first-page":"550","article-title":"The interplay between autophagy and regulated necrosis","volume":"38","author":"Zhang","year":"2023","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2025.118275_bib54","article-title":"The Role of the interplay between autophagy and NLRP3 inflammasome in metabolic disorders","volume":"9","author":"Lv","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118275_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.831847","article-title":"The induction of endothelial autophagy and its role in the development of atherosclerosis","volume":"9","author":"Hua","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.118275_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2011.09.048","article-title":"Effect of cilostazol on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials","volume":"220","author":"Geng","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2025.118275_bib57","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/jpm12060938","article-title":"A randomized controlled trial evaluating outcome impact of cilostazol in patients with coronary artery disease or at a high risk of cardiovascular disease","volume":"12","author":"Lin","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.biopha.2025.118275_bib58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ajh.2008.6","article-title":"Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes","volume":"21","author":"Suzuki","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biopha.2025.118275_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12476","article-title":"Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice","volume":"36","author":"Park","year":"2018","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.biopha.2025.118275_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/fcp.12195","article-title":"Cilostazol exerts antiplatelet and anti-inflammatory effects through AMPK activation and NF-kB inhibition on hypercholesterolemic rats","volume":"30","author":"da Motta","year":"2016","journal-title":"Fundam. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.118275_bib61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5551\/jat.E492","article-title":"Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP","volume":"14","author":"Mori","year":"2007","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.biopha.2025.118275_bib62","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00210-022-02233-3","article-title":"Cilostazol attenuates cardiac oxidative stress and inflammation in hypercholesterolemic rats","volume":"395","author":"de Oliveira Lopes","year":"2022","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2025.118275_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12929-019-0550-9","article-title":"Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE\/ERK\/NF-\u03baB signaling pathways","volume":"26","author":"Su","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2025.118275_bib64","first-page":"1028","article-title":"Cilostazol induces eNOS and TM expression via activation with sirtuin 1\/kruppel-like factor 2 pathway in endothelial cells","volume":"22","author":"Wu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118275_bib65","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/ATVBAHA.108.164368","article-title":"Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells","volume":"28","author":"Ota","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2025.118275_bib66","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/dom.13667","article-title":"Effect of cilostazol, a phosphodiesterase-3 inhibitor, on coronary artery stenosis and plaque characteristics in patients with type 2 diabetes: ESCAPE study","volume":"21","author":"Lee","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2025.118275_bib67","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/dom.14147","article-title":"Effect of cilostazol on carotid plaque volume measured by three-dimensional ultrasonography in patients with type 2 diabetes: the FANCY study","volume":"22","author":"Lee","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2025.118275_bib68","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10557-021-07187-x","article-title":"Cilostazol: a review of basic mechanisms and clinical uses","volume":"36","author":"Kherallah","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2025.118275_bib69","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.amjcard.2012.01.349","article-title":"Meta-analysis of randomized controlled trials on effect of cilostazol on restenosis rates and outcomes after percutaneous coronary intervention","volume":"109","author":"Friedland","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.118275_bib70","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/1753-0407.13300","article-title":"Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: long-term follow-up of the ESCAPE study","volume":"14","author":"Sohn","year":"2022","journal-title":"J. Diabetes"},{"key":"10.1016\/j.biopha.2025.118275_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500469X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500469X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:48:59Z","timestamp":1754653739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500469X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":71,"alternative-id":["S075333222500469X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118275","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol attenuates vascular inflammation via the regulation of TICAM1\/IRF3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118275"}}